Published May 24, 2018
| Version v1
Dataset
Open
Screening EGFR and GAK Inhibitors in Chordoma
- 1. Catalyst for Rare Diseases, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
- 2. Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
Description
Screening of inhibitors of the kinases EGFR and GAK in chordoma cell models to investigate the roles of each kinase in the biology of this rare cancer.
Notes
The Catalyst for Rare Diseases at the UNC Eshelman School of Pharmacy is funded by the Eshelman Institute for Innovation.
Files
20180522 Zenodo.pdf
Files
(431.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:120772466f652bf3e8642221aee17537
|
431.0 kB | Preview Download |